Nov 24, 2025 07:30AM
Nov 24, 2025 07:30AM
Nov 14, 2025 04:05PM
Nov 14, 2025 04:05PM
Nov 3, 2025 07:32AM
Sep 18, 2025 07:40AM
Sep 18, 2025 07:40AM Biogen to Acquire Alcyone Therapeutics, Expanding Drug Delivery Solution Portfolio for Key Product and Pipeline Candidates
Sep 17, 2025 04:30PM
Sep 17, 2025 04:30PM
Jul 2, 2025 10:00AM
Jun 25, 2025 07:31AM
Jun 25, 2025 07:30AM
Jun 18, 2025 07:31AM
Jun 18, 2025 07:30AM Biogen Initiates Phase 3 Pediatric Study of Omaveloxolone for the Treatment of Friedreich Ataxia
Jun 12, 2025 01:00AM
May 27, 2025 07:30AM
Apr 22, 2025 05:14AM
Apr 1, 2025 07:31AM
Apr 1, 2025 07:30AM
Mar 20, 2025 08:00AM
Mar 15, 2025 04:00PM Bernstein provides 2025 M&A outlook for U.S. Biotech and Pharma
Feb 18, 2025 04:04PM
Feb 18, 2025 08:03AM
Feb 18, 2025 08:00AM
Feb 18, 2025 06:00AM
Feb 12, 2025 06:47AM
Jan 27, 2025 09:21AM
Jan 27, 2025 09:21AM SAGE Therapeutics (SAGE) Explores Strategic Alternatives
Jan 27, 2025 09:20AM
Jan 15, 2025 10:33AM
Jan 13, 2025 07:42AM
Jan 10, 2025 06:49PM
Nov 19, 2024 01:00AM
Oct 30, 2024 04:54PM
Sep 24, 2024 06:22AM Biogen (BIIB) and UCB Report Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus
Sep 24, 2024 01:00AM
Aug 1, 2024 07:27AM
Jul 16, 2024 05:10AM
Jul 4, 2024 10:20AM
Jul 2, 2024 04:02PM
Jul 2, 2024 09:17AM
Jul 2, 2024 09:16AM Biogen Completes Acquisition of Human Immunology Biosciences
Jul 1, 2024 09:00PM
Jul 1, 2024 07:00AM
Jun 28, 2024 09:40AM
Jun 27, 2024 09:00PM
Jun 24, 2024 03:46PM
Jun 23, 2024 09:00PM
Jun 19, 2024 09:00PM Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Biogen, Charge, and Fastly and Encourages Investors to Contact the Firm
Jun 17, 2024 07:15AM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All